TCTR20190831003进行中（未招募）未知
The study of health state utility of diabetic retinopathy from EQ-5D-5L, Time trade off and HUI3
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 320 人开始时间: 2019年8月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 999 Years（—）
- 性别
- All
入选标准
- •Inclusion criteria for DR
- •1.Type 2 diabetes patient age> 18 years old
- •2.No other intraocular disease that effect functioning of vision such as primary open angle glaucoma , retinal vascular occlusion , hereditary retina disease , ocular inflammation , central serous chorioretinopathy, macular hole, rhegmatogenous retinal detachment or other disease that interfere vision except diabetic complications: DME, TRD, NVG and VH . ERM without macular hole is included in the study.
- •3.No cataract more than NS2+/PSC1+/CC2+
- •4.No history of Alzheimer’s disease, Dementia or poor mental health status or on current treatment of psychotic/antidepressant medication
- •5.No history of any ocular surgery within 3 months
- •6.Native Thai speaking
- •Inclusion criteria for cataract
- •1.Any cataract age> 18 years old
- •2.No other intraocular disease that effect functioning of vision such as primary open angle glaucoma , retinal vascular occlusion , hereditary retina disease , ocular inflammation , central serous chorioretinopathy, macular hole, diabetic retinopathy rhegmatogenous retinal detachment, wet-age related macular degeneration or any ocular condition that alter vision except from cataract.
- •3.No history of Alzheimer’s disease, Dementia or poor mental health status or on current treatment of psychotic/antidepressant medication
- •4.No history of any ocular surgery within 3 months
- •5.Native Thai speaking
- •Inclusion criteria for Wet age-related macular degeneration
- •1.Any wet AMD age> 18 years old
- •2.No other intraocular disease that effect functioning of vision such as primary open angle glaucoma , retinal vascular occlusion , hereditary retina disease , ocular inflammation , central serous chorioretinopathy, macular hole, diabetic retinopathy rhegmatogenous retinal มDME, TRD, NVG and VH .
- •3.No cataract more than NS2+/PSC1+/CC2+
- •4.No history of Alzheimer’s disease, Dementia or poor mental health status or on current treatment of psychotic/antidepressant medication
- •5.No history of any ocular surgery within 3 months
- •6.Native Thai speaking
排除标准
- •Exclusion criteria for DR
- •1.Patient who is not willing to complete the interview or unwilling to answer the question
- •2.Dense posterior capsular opacity in pseudophakic patient that interfere visual acuity
- •3.Patient/respondents who indicated for not understand the task on a feasibility questionnaire
- •4.Patient/respondents who did not differentiate between any of different health states
- •5.Patient/respondents who did not trade off any time (non -trader)
- •6.Patient/respondents who use time for each task more than 150% of average time from pilot study
- •Exclusion criteria for cataract
- •1.Patient who is not willing to complete the interview or unwilling to answer the question
- •2.Patient/respondents who indicated for not understand the task on a feasibility questionnaire
- •3.Patient/respondents who did not differentiate between any of different health states
- •4.Patient/respondents who did not trade off any time (non -trader)
- •5.Patient/respondents who use time for each task more than 150% of average time from pilot study
- •Exclusion criteria for W AMD
- •1.Patient who is not willing to complete the interview or unwilling to answer the question
- •2.Patient/respondents who indicated for not understand the task on a feasibility questionnaire
- •3.Patient/respondents who did not differentiate between any of different health states
- •4.Patient/respondents who did not trade off any time (non -trader)
- •5.Patient/respondents who use time for each task more than 150% of average time from pilot study
研究者
相似试验
尚未招募
1 期
A research for the clinical validity of Diabetes decoction which was set up by national medical master professor Yan Dexin and was used for treating type 2 diabetes with spleen-deficiency and blood-stasis syndrome in the early periodType 2 diabetesITMCTR1900002699Shanghai Traditional Chinese Medicine Hospital
招募中
2 期
Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT06010992Tanta University70
尚未招募
不适用
Diabetes REarCh on patient sTratification (DIRECT) work package 3.2: metformin intolerance1001842410012653Type 2 Diabetes MellitusNL-OMON38746Vrije Universiteit Medisch Centrum150
已完成
不适用
The effect of diabetes and diabetic control status on clinical manifestations and treatment response in patients of pulmonary tuberculosisCertain infectious and parasitic diseasesKCT0000760Chung-Ang Univerisity Hospital1,384
招募中
不适用
Diabetic rehabilitation effect on type 2 diabetic patients and their family caregiversIRCT20200313046758N1Shiraz University of Medical Sciences156